MAPT and Alzheimer disease: These changes lead to a deregulation of intracellular calcium levels, which in turn enhance AD ́s hallmarks such as tau phosphorylation and Aβ peptide accumulation, thereby exacerbating neurotoxicity (Querfurth and Selkoe 1994; Pierrot et al. 2006).